MLKL and melanoma: The murine oral squamous cell carcinoma cell line MOC1 showed particularly high in vivo responsiveness to ICI immunotherapy, which similarly to B16 melanoma was completely dependent on tumor cell-intrinsic MLKL activity (online supplemental figure S5C).